SPECIAL NOTICE
66 -- Notice of Intent to Sole Source to Procure ProcartaPlex 384-Well Multiplex (4-plex) Human Cytokine Assay kits
- Notice Date
- 8/17/2023 12:38:09 PM
- Notice Type
- Special Notice
- Contracting Office
- ARMY MED RES ACQ ACTIVITY FORT DETRICK MD 21702 USA
- ZIP Code
- 21702
- Solicitation Number
- PANMRA-23-P-0000-006563
- Response Due
- 8/24/2023 1:00:00 PM
- Archive Date
- 09/08/2023
- Point of Contact
- Karyn Williams, Phone: 3016199524, Jesse Nisley, Phone: 3016197763
- E-Mail Address
-
karyn.m.williams2.civ@health.mil, jesse.d.nisley.civ@health.mil
(karyn.m.williams2.civ@health.mil, jesse.d.nisley.civ@health.mil)
- Description
- This is a notice of intent to issue an award on the basis of other than full and open competition under Federal Acquisition Regulation (FAR) 13.106-1(b)(1) in accordance with 41 U.S.C. 1901. The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a firm-fixed price contract to Fisher Scientific Company, L.L.C. located at 300 Industry DR Pittsburgh, Pennsylvania 15275-1001 in support of the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). The requirement is to procure a quantity of 11 PROCARTAPLEX 4 PLEX 384 test kits for human cytokines in cell culture supernatants [analytes: IL-6, IL-8 (CXCL8), TNF alpha, IL-1 beta].� The USAMRICD owns and operates a 384-well Luminex xMAP INTELLLIFLEX system. Therefore, only assay kits that are compatible with this system are being considered for procurement. These kits are required to accomplish milestones with the necessary continuity under an approved funded research program. The required item is manufactured by Life Technologies Corporation, a subsidiary of Thermo Fisher, and sold exclusively through Thermo Fisher. The North American Industry Classification System (NAICS) for this requirement is 334516: Analytical Laboratory Instrument Manufacturing; and PSC 6640, Laboratory Equipment and Supplies. This notice of intent is not a request for competitive proposals and no solicitation document will be posted for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. Submissions that request documentation, request additional information or that solely ask questions will be determined to not be an affirmative response. Responses determined to be not an affirmative response are not valid and no further action will be taken with the response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. This announcement fulfills the synopsis requirements under FAR 5.102(a)(6) and 5.203(a). If no written responses are received by the date listed below, which reflects at least seven (7) days after the publication of this notice, the solicitation will be issued as sole source. Based on the above information, the only source that can meet the Government�s requirement is Fisher Scientific Company, L.L.C.. Please submit email capabilities statements (using PDF, MS Word, Excel attachments) to Karyn Williams at karyn.m.williams2.civ@health.mil. �Statements are due no later than 4:00 P.M. Eastern Daylight Time (EDT) on 24 August 2023. No phone calls accepted.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/e3e9e5411f2547c595341b4a1e4e52c1/view)
- Place of Performance
- Address: Gunpowder, MD 21010, USA
- Zip Code: 21010
- Country: USA
- Zip Code: 21010
- Record
- SN06794577-F 20230819/230817230046 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |